| Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 365 (9472), 1687-1717, 2005 | 7743 | 2005 |
| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005 | 6159 | 2005 |
| Tamoxifen for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 351 (9114), 1451-1467, 1998 | 3966 | 1998 |
| Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 … Early Breast Cancer Trialists' Collaborative Group The Lancet 378 (9804), 1707-1716, 2011 | 3809 | 2011 |
| Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials EBCTC Group The lancet 378 (9793), 771-784, 2011 | 2996 | 2011 |
| Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, JF Forbes, ... Lancet 365 (9453), 60-62, 2005 | 2958 | 2005 |
| Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials EBCTC Group The Lancet 379 (9814), 432-444, 2012 | 2189 | 2012 |
| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 2157 | 1998 |
| Trastuzumab emtansine for residual invasive HER2-positive breast cancer G Von Minckwitz, CS Huang, MS Mano, S Loibl, EP Mamounas, M Untch, ... New England Journal of Medicine 380 (7), 617-628, 2019 | 2112 | 2019 |
| Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC … A The The Lancet 359 (9324), 2131-2139, 2002 | 2094 | 2002 |
| Palbociclib in hormone-receptor–positive advanced breast cancer NC Turner, J Ro, F André, S Loi, S Verma, H Iwata, N Harbeck, S Loibl, ... New England Journal of Medicine 373 (3), 209-219, 2015 | 1667 | 2015 |
| Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer G Von Minckwitz, M Procter, E De Azambuja, D Zardavas, M Benyunes, ... New England Journal of Medicine 377 (2), 122-131, 2017 | 1449 | 2017 |
| 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years H Pan, R Gray, J Braybrooke, C Davies, C Taylor, P McGale, R Peto, ... New England Journal of Medicine 377 (19), 1836-1846, 2017 | 1373 | 2017 |
| Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1341-1352, 2015 | 1274 | 2015 |
| Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 355 (9217), 1757-1770, 2000 | 1261 | 2000 |
| Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer Early Breast Cancer Trialists' Collaborative Group New England journal of medicine 319 (26), 1681-1692, 1988 | 1058 | 1988 |
| Phase III randomized study of ribociclib and fulvestrant in hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: MONALEESA-3 DJ Slamon, P Neven, S Chia, PA Fasching, M De Laurentiis, SA Im, ... Journal of Clinical Oncology 36 (24), 2465-2472, 2018 | 941 | 2018 |
| Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer: results of the ATAC … ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group Cancer 98 (9), 1802-1810, 2003 | 893 | 2003 |
| Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial D Tripathy, SA Im, M Colleoni, F Franke, A Bardia, N Harbeck, SA Hurvitz, ... The lancet oncology 19 (7), 904-915, 2018 | 891 | 2018 |
| Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) Journal of the National Cancer Institute Monographs 2010 (41), 162-177, 2010 | 710 | 2010 |
Sabino De PlacidoProfessore Ordinario di Oncologia MedicaVerified email at unina.it
